Brugada Syndrome Diagnosed with COVID-19 Infection

The COVID-19 outbreak is a global public health problem, the disease has spread exponentially since the late December 2019, when the first cases of SARS-CoV-2 infection were detected in Wuhan, China. Fever is the most common symptom in about 88% of cases, cough (68%), vomiting (5%), and diarrhea (3.8%) are the other common symptoms. In this case report, a 34-year-old male patient admitted to the emergency department with fever lasting for 3 days. The first diagnostic study, including documented computed tomography scan, was consistent with viral pneumonia and the 12 lead electrocardiogram (ECG) showed a Brugada-type I pattern, ST segment elevation in the right precordial leads with no reciprocal changes. The patient had no chest pain, or syncope or a family history of sudden cardiac death. Cardiac enzymes were normal and echocardiographic examination showed normal wall motions and there was no pericardial effusion. The patient was hospitalized with a diagnosis of COVID-19 pneumonia confirmed by a positive nasopharyngeal swab test for COVID-19. Brugada syndrome is a rare disease manifested by ST-segment elevation in the right precordial leads. Fever may cause Brugada-like changes in the ECG. With the reduction of fever, the Brugada-like ECG changes also disappeared.